ORGANIC
LETTERS
2011
Vol. 13, No. 11
2916–2919
Facile and Enantiospecific Syntheses of
(6S,7R)-6-Chloro-7-benzyloxy-, (7S)-Halo-,
and (7S)-Hydroxy-cocaine and Natural
(ꢀ)-Cocaine from D-(ꢀ)-Ribose
Tony K. M. Shing* and King H. So
Department of Chemistry and Center of Novel Functional Molecules, The Chinese
University of Hong Kong, Shatin, NT, Hong Kong, China
Received April 13, 2011
ABSTRACT
First syntheses of C6,7 and C7 enantiopure cocaine analogues were achieved from D-(ꢀ)-ribose via a trans-acetonide controlled endo-selective
intramolecular nitrone-alkene cycloaddition (INAC) as the key step. This synthetic scheme allows practical preparation of cocaine analogues for
bioevaluation as potential candidates for the treatment of cocaine addiction and as potential conjugates for immunotherapy.
Notorious tropane alkaloid (ꢀ)-cocaine (1)1 is a power-
ful stimulant of the central nervous system, and its neuro-
nal reinforcing properties are attributable to its inhibition
of dopamine reuptake.2 Cocaine abuse has been a pivotal
medical problem in the world, and 1.6 million current users
by age 12 are estimated in the U.S.3 Furthermore, cocaine
abuse has indirectly enhanced the spread of human im-
munodeficiency virus infection and drug-resistant tube-
rculcosis.4 To date, aneffective medication totreat patients
addicted to cocaine is still elusive and research effort on the
synthesis of cocaine analogues for bioevaluation must
continue. Tremendous studies have been made on C2
and C3 cocaine analogues, but C6 and C7 analogues are
relatively underexplored.5,6 This is because C2 and C3
analogues were readily derived from (ꢀ)-cocaine (1)
whereas access to C6 and C7 analogues must rely on total
synthesis. Existing C6 and C7 analogues were synthesized
€
as racemates by modifying the classical Willstatter synth-
esis of cocaine.5a,b Resolution is required to produce
enantiopure analogues which hampers the development
of a pharmacotherapy. Recently, Davis et al. described
the asymmetric synthesis of cocaine C1-alkyl analogues
using essentially an asymmetric variant of the Tufariello
(5) For some reports of synthesis of cocaine analogues, see: (a)
racemic 6β- and 7β-methoxylated cocaine: Simoni, D.; Stoelwinder, J.;
Kozikowski, A. P.; Johnson, K. M.; Bergmann, J. S.; Ball, R. G. J. Med.
Chem. 1993, 36, 3975–3977. (b) racemic 6β- and 7β-hydroxylated
cocaine: Kozikowski, A. P.; Simoni, D.; Manfredini, S.; Roberti, M.;
Stoelwinder, J. Tetrahedron Lett. 1996, 37, 5333–5336. (c) enantiopure
C1-alkyl cocaine analogues: Davis, F. A.; Theddu, N.; Edupuganti, R.
Org. Lett. 2010, 12, 4118–4121.
(6) For some reports of synthesis of C2 and C3 tropane analogues,
see: (a) Carroll, F. I.; Blough, B. E.; Mascarella, S. W.; Navarro, H. A.;
Eaton, J. B.; Lukas, R. J.; Damaj, M. I. J. Med. Chem. 2010, 53, 8345–
8353. (b) Stehouwer, J. S.; Jarkas, N.; Zeng, F.; Voll, R. J.; Williams, L.;
Camp, V. M.; Malveaux, E. J.; Votaw, J. R.; Howell, L.; Owens, M. J.;
Goodman, M. M. J. Med. Chem. 2008, 51, 7788–7799. (c) Zhang, S.;
Izenwasser, S.; Wade, D.; Xu, L.; Trudell, M. L. Bioorg. Med. Chem.
2006, 14, 7943–7952. (d) Bois, F.; Baldwin, R. M.; Kula, N. S.; Baldes-
sarini, R. J.; Innis, R. B.; Tamagnan, G. Bioorg. Med. Chem. Lett. 2004,
14, 2117–2120. (e) Zhao, L.; Johnson, K. M.; Zhang, M.; Flippen-
Anderson, J.; Kozikowski, A. P. J. Med. Chem. 2000, 43, 3283–3294.
(1) Simoni, D.; Rondanin, R.; Roberti, M. In Targets in Heterocyclic
Systems; Attanasi, O. A., Spinelli, D., Eds.; Italian Society of Chemistry:
Roma, 1999; Vol. 3, pp 147ꢀ183.
(2) (a) Ritz, M. C.; Lamb, R. J.; Goldberg, S. R.; Kuhar, M. J.
Science 1987, 237, 1219–1223. (b) Kuhar, M. J.; Ritz, M. C.; Boja, J. W.
Trends Neurosci. 1991, 14, 299–302. (c) Koob, G. F.; Bloom, F. E.
Science 1988, 242, 715–723.
(3) Substance Abuse and Mental Health Services Administration.
(2010). Results from the 2009 National Survey on Drug Use and Health:
Vol. I. Page 1. Summary of National Findings (Office of Applied Studies,
NSDUH Series H-38A, HHS Publication No. SMA 10ꢀ4586Findings),
(4) Herman, B. H.; Elkashef, A.; Vocci, F. Drug Discovery Today:
Therapeutic Strategies 2005, 2, 87–92.
r
10.1021/ol2009686
Published on Web 05/05/2011
2011 American Chemical Society